Estradiol and Levonorgestrel Transdermal System is primarily used treat moderate to severe symptoms of menopause ...
Biotech firm Zealand Pharma has reported positive Phase 1 multiple ascending dose (MAD) results for ZP9830, its ...
Eli Lilly and Company has reported positive one-year results from a Phase 3 trial of Omvoh (mirikizumab-mrkz) in children and adolescents aged 6 to 17 with moderately to severely active ulcerative ...
The initiative aims to address persistent gaps in healthcare, including late diagnosis, delays in specialist referrals ...
AbbVie’s investigational dual-targeting therapy ABBV-466 has demonstrated higher rates of endoscopic remission than either of ...
Lysine is one of the most limiting amino acids in ruminant nutrition and a critical driver of animal performance ...
The updated recommendation adds to the drug’s existing Category 2A designation for metastatic cutaneous squamous cell ...
NATCO Pharma announces launch of Carboplatin Injection, a generic version of Paraplatin in the US market by its US subsidiary ...
A unified lab ecosystem drives innovation across life and materials sciences through coordinated scientific workflows ...
These awards for Tanuku and Patalganga teams recognize their dedication to a safe, compliant and rewarding workplace ...
For millions of office workers, sitting at a desk for eight hours or more has become part of the daily grind. But doctors are ...
Roche has secured US FDA approval for Enspryng (satralizumab) to treat adults with thyroid eye disease (TED), introducing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results